These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28393576)

  • 21. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
    Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
    J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-Based Minireview: Full dose, modified dose, or no anticoagulation for patients with cancer and acute VTE and thrombocytopenia.
    Patell R; Zwicker JI
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):312-315. PubMed ID: 36485075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
    Squizzato A; Galliazzo S; Rancan E; Di Pilla M; Micucci G; Podda G; Valeriani E; Campiotti L; Bertù L; Ageno W; Porreca E; Lodigiani C
    Intern Emerg Med; 2022 Jan; 17(1):83-90. PubMed ID: 34110563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
    Shaw J; de Wit C; Le Gal G; Carrier M
    J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Blood Adv; 2019 Nov; 3(22):3770-3779. PubMed ID: 31770442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulants in patients with hematologic malignancies.
    Serrao A; Fiori L; Santoro C; De Luca ML; Ferretti A; De Luca G; Ligia S; Lapietra G; Mohamed S; Breccia M; Chistolini A
    Hematol Oncol; 2020 Oct; 38(4):589-596. PubMed ID: 32588912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
    Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy.
    Livneh N; Braeken D; Drozdinsky G; Gafter-Gvili A; Seelig J; Rozovski U; Berger T; Raanani P; Falanga A; Ten Cate H; Spectre G; Leader A
    J Thromb Thrombolysis; 2021 Aug; 52(2):590-596. PubMed ID: 33523384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulants in patients with venous thromboembolism and hematological malignancies.
    Robinson R; Spectre G; Lishner M; Sharabi O; Robinson E; Hamburger Avnery O; Gafter-Gvili A; Raanani P; Leader A
    J Thromb Thrombolysis; 2023 May; 55(4):729-736. PubMed ID: 36943661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort.
    Booth S; ; Desborough M; Curry N; Stanworth S
    J Thromb Haemost; 2022 Aug; 20(8):1830-1838. PubMed ID: 35505495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism.
    Lange N; Méan M; Stalder O; Limacher A; Tritschler T; Rodondi N; Aujesky D
    Thromb Res; 2019 May; 177():10-16. PubMed ID: 30826719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
    Chen J; Bi G; Wu F; Qin X
    Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
    Lecumberri R; Ruiz-Artacho P; Trujillo-Santos J; Brenner B; Barillari G; Ruiz-Ruiz J; Lorente MA; Verhamme P; Vázquez FJ; Weinberg I; Monreal M;
    Thromb Res; 2020 Nov; 195():139-145. PubMed ID: 32693201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.